Skip to main content

Coronavirus Update: Gilead's Remdesivir Will Cost $2,340 for 5 Day Treatment

Publish date:
Video Duration:

Good morning, it’s Monday, June 29. 

Here’s your daily coronavirus update.

There are 10.1 million cases of the virus worldwide, with over 502,000 deaths.

The U.S. has 2.5 million cases and 125,000 deaths.

Brazil has 1.3 million cases and 57,000 deaths.

On Saturday, the U.S. reported 42,000 cases. This was the second straight day that the U.S. reported an upwards of 40,000 cases in a single day. On Friday, the U.S. reported 45,000.

California governor Gavin Newsom has required that bars are closed in seven counties, including Los Angeles, and the state has recommended they be closed in eight others.

Floria Gov. Ron DeSantis said people in the 18-to-44 age group accounted for most of the rise in positive virus tests.

“For these younger groups, they need to be thinking about who they’re coming into contact with who may be in the more vulnerable groups,” said DeSantis at a news conference Sunday.

India has recorded its biggest one-day jump in new coronavirus cases, 19,400 new cases have been reported Monday, per the country’s health ministry. This means that India has reported 100,000 new COVID-19 infections in the past six days.

And Gilead announced that its remdesivir drug, which is being used to treat the coronavirus, will cost around $390 a vial. But, due to the U.S. healthcare programs, the price per vial will be $520 for private insurance.

Gilead, in a press release, noted that--based on current treatment patterns--this will cost around $2,340 a patient in developed countries.

"There is no playbook for how to price a new medicine in a pandemic," said CEO Daniel O’Day.

You can follow Katherine Ross on Twitter at @byKatherineRoss.

Read more from Katherine Ross here.

Watch More Videos From TheStreet and Jim Cramer:

Related Videos